Free Trial
NASDAQ:RGC

Regencell Bioscience (RGC) Stock Price, News & Analysis

Regencell Bioscience logo
$12.80 +0.24 (+1.91%)
As of 08/22/2025 04:00 PM Eastern

About Regencell Bioscience Stock (NASDAQ:RGC)

Key Stats

Today's Range
$12.52
$13.00
50-Day Range
$10.36
$63.35
52-Week Range
$0.09
$83.60
Volume
164,026 shs
Average Volume
276,609 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Regencell Bioscience Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
1st Percentile Overall Score

RGC MarketRank™: 

Regencell Bioscience scored higher than 1% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Regencell Bioscience.

  • Price to Book Value per Share Ratio

    Regencell Bioscience has a P/B Ratio of 640.00. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.46% of the float of Regencell Bioscience has been sold short.
  • Short Interest Ratio / Days to Cover

    Regencell Bioscience has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Regencell Bioscience has recently increased by 23.63%, indicating that investor sentiment is decreasing significantly.
  • Percentage of Shares Shorted

    0.46% of the float of Regencell Bioscience has been sold short.
  • Short Interest Ratio / Days to Cover

    Regencell Bioscience has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Regencell Bioscience has recently increased by 23.63%, indicating that investor sentiment is decreasing significantly.
  • Search Interest

    Only 9 people have searched for RGC on MarketBeat in the last 30 days. This is a decrease of -69% compared to the previous 30 days.
  • MarketBeat Follows

    Only 3 people have added Regencell Bioscience to their MarketBeat watchlist in the last 30 days. This is a decrease of -87% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Regencell Bioscience insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 2.00% of the stock of Regencell Bioscience is held by insiders.

  • Percentage Held by Institutions

    Only 0.13% of the stock of Regencell Bioscience is held by institutions.

  • Read more about Regencell Bioscience's insider trading history.
Receive RGC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Regencell Bioscience and its competitors with MarketBeat's FREE daily newsletter.

RGC Stock News Headlines

RGC Resources: The Impact Of MVP
He Called Nvidia at $1.10. Now, He Says THIS Stock Will…
The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvidia at $1.10 reveals AI’s Next Magnificent Seven… including one stock he says could become America’s next trillion-dollar giant.tc pixel
See More Headlines

RGC Stock Analysis - Frequently Asked Questions

Regencell Bioscience's stock was trading at $63.35 at the beginning of 2025. Since then, RGC stock has decreased by 79.8% and is now trading at $12.80.

Regencell Bioscience's stock split on Monday, June 16th 2025.The 38-1 split was announced on Monday, June 2nd 2025. The newly created shares were payable to shareholders after the market closes on Sunday, June 15th 2025. An investor that had 100 shares of stock prior to the split would have 3,800 shares after the split.

Regencell Bioscience (RGC) raised $22 million in an IPO on Friday, July 16th 2021. The company issued 2,300,000 shares at a price of $8.50-$10.50 per share.

Regencell Bioscience's top institutional investors include Geode Capital Management LLC, Squarepoint Ops LLC, BNP Paribas Financial Markets and Y Intercept Hong Kong Ltd.

Shares of RGC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
8/23/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Medicinal Chemicals
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:RGC
Previous Symbol
NASDAQ:RGC
CIK
1829667
Web
N/A
Employees
10
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.02 per share
Price / Book
640.00

Miscellaneous

Outstanding Shares
494,490,000
Free Float
N/A
Market Cap
$6.33 billion
Optionable
N/A
Beta
2.20
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:RGC) was last updated on 8/23/2025 by MarketBeat.com Staff
From Our Partners